Jonathan Piazza

Insider Reports History

Entity
Individual
Location
C/O Silverback Therapeutics, Inc., 500 Fairview Avenue N, Suite 600, Seattle, WA
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Piazza:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Silverback Therapeutics, Inc. Chief Financial Officer Common Stock 69.2K $262K $3.78 May 2, 2022 Direct
Silverback Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 87.4K May 2, 2022 Direct

Insider Reports Filed by Jonathan Piazza

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SPRY Silverback Therapeutics, Inc. May 2, 2022 2 $0 4 May 4, 2022 Chief Financial Officer
SPRY Silverback Therapeutics, Inc. Feb 1, 2022 3 $0 4 Feb 2, 2022 Chief Financial Officer